Zentalis Pharmaceuticals, Inc. (ZNTL) Current Income Tax Expense (Benefit)

Zentalis Pharmaceuticals, Inc. Current Income Tax Expense (Benefit)

Zentalis Pharmaceuticals, Inc. (ZNTL) reported Current Income Tax Expense (Benefit) of $391.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.

Financial Statements › Expense Statement › Income Tax

us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-03-26

• Zentalis Pharmaceuticals, Inc. current income tax expense (benefit) for fiscal 2025 was $391.00K, a 62.92% increase from fiscal 2024.
• Zentalis Pharmaceuticals, Inc. current income tax expense (benefit) for fiscal 2024 was $240.00K, a 17.24% decline from fiscal 2023.
• Zentalis Pharmaceuticals, Inc. current income tax expense (benefit) for fiscal 2023 was $290.00K, a 6.15% decline from fiscal 2022.
• Zentalis Pharmaceuticals, Inc. current income tax expense (benefit) for fiscal 2022 was $309.00K, a 44.92% decline from fiscal 2021.